Analgesics (Pharmacies) - Southeast Asia

Revenue in the Analgesics market is projected to reach US$688.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.36%, resulting in a market volume of US$1.03bn by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$0.99 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Southeast Asia is experiencing significant growth and development due to several key factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the current state of the market. Customer preferences in Southeast Asia are driving the demand for analgesics in pharmacies. With the region's growing population and increasing healthcare awareness, more people are seeking over-the-counter pain relief options. Consumers in Southeast Asia are also becoming more health-conscious and proactive in managing their well-being, leading to a higher demand for analgesics in pharmacies. Trends in the market further contribute to the growth of the Analgesics (Pharmacies) market in Southeast Asia. One notable trend is the rising prevalence of chronic diseases such as arthritis and back pain, which require long-term pain management. As a result, there is a growing need for analgesics that provide effective and sustained relief. Additionally, the increasing popularity of online shopping platforms has made it easier for consumers to access a wide range of analgesics from various brands and suppliers, further driving market growth. Local special circumstances also play a role in the development of the Analgesics (Pharmacies) market in Southeast Asia. For example, in countries with a large elderly population, such as Singapore and Thailand, there is a higher demand for analgesics due to age-related ailments and chronic pain conditions. Furthermore, the presence of a well-established pharmacy network across the region ensures easy accessibility to analgesics, making them a convenient choice for consumers. Underlying macroeconomic factors contribute to the overall growth and development of the Analgesics (Pharmacies) market in Southeast Asia. The region's strong economic growth and rising disposable incomes have led to an increase in healthcare spending. As a result, consumers are more willing to invest in pain relief options, driving the demand for analgesics. Additionally, the expanding middle class in Southeast Asia is becoming more health-conscious and willing to spend on preventive healthcare, further fueling the market growth. In conclusion, the Analgesics (Pharmacies) market in Southeast Asia is experiencing significant growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The region's growing population, increasing healthcare awareness, and rising prevalence of chronic diseases are driving the demand for analgesics. The availability of a wide range of analgesics through online platforms and a well-established pharmacy network further contribute to market growth. Additionally, the region's strong economic growth and rising disposable incomes have led to increased healthcare spending, making analgesics a popular choice for consumers in Southeast Asia.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.